# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5252126 | P | Lipophilicity, logD of the compound at pH 7.4 | 15 | small-molecule physicochemical format | Scientific Literature | |||
2. | ALA5252128 | B | Inhibition of Escherichia coli TrmD | Escherichia coli | 38 | single protein format | Scientific Literature | ||
3. | ALA5252129 | F | Antibacterial activity against Haemophilus influenzae ATCC 49247 assessed as inhibition of bacterial growth | Haemophilus influenzae | 15 | organism-based format | Scientific Literature | ||
4. | ALA5252130 | F | Antibacterial activity against efflux-defective Escherichia coli N43 deficit of AcrAB-TolC assessed as inhibition of bacterial growth | Escherichia coli | 15 | organism-based format | Scientific Literature | ||
5. | ALA5252132 | F | Antibacterial activity against efflux-defective Escherichia coli N43 deficit of AcrAB-TolC assessed as inhibition of bacterial growth in presence of 4 ug/ml membrane-permeabilising agent, polymyxin B | Escherichia coli | 15 | organism-based format | Scientific Literature | ||
6. | ALA5252133 | F | Antibacterial activity against Neisseria gonorrhoeae ATCC 49226 assessed as inhibition of bacterial growth | Neisseria gonorrhoeae | 3 | organism-based format | Scientific Literature | ||
7. | ALA5252134 | F | Antibacterial activity against Acinetobacter baumannii NCTC 13420 assessed as inhibition of bacterial growth | Acinetobacter baumannii | 3 | organism-based format | Scientific Literature | ||
8. | ALA5252135 | F | Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as inhibition of bacterial growth | Bacillus subtilis | 3 | organism-based format | Scientific Literature | ||
9. | ALA5252136 | F | Antibacterial activity against Francisella tularensis-Schu S4 assessed as inhibition of bacterial growth | Francisella tularensis | 3 | organism-based format | Scientific Literature | ||
10. | ALA5252137 | F | Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth | Pseudomonas aeruginosa | 3 | organism-based format | Scientific Literature | ||
11. | ALA5252138 | F | Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as inhibition of bacterial growth | Staphylococcus epidermidis | 3 | organism-based format | Scientific Literature | ||
12. | ALA5252139 | F | Antibacterial activity against Burkholderia cepacia ATCC 25416 assessed as inhibition of bacterial growth | Burkholderia cepacia | 3 | organism-based format | Scientific Literature | ||
13. | ALA5252140 | F | Antibacterial activity against Enterococcus faecium ATCC 19434 assessed as inhibition of bacterial growth | Enterococcus faecium | 3 | organism-based format | Scientific Literature | ||
14. | ALA5252141 | F | Antibacterial activity against Streptococcus pneumoniae ATCC 49619 assessed as inhibition of bacterial growth | Streptococcus pneumoniae | 3 | organism-based format | Scientific Literature | ||
15. | ALA5252142 | F | Antibacterial activity against Moraxella catarrhalis ATCC 25240 assessed as inhibition of bacterial growth | Moraxella catarrhalis | 3 | organism-based format | Scientific Literature | ||
16. | ALA5252143 | F | Antibacterial activity against Yersinia pestis CO92 assessed as inhibition of bacterial growth | Yersinia pestis | 3 | organism-based format | Scientific Literature | ||
17. | ALA5252144 | F | Antibacterial activity against Coxiella burnetii Nine Mile assessed as inhibition of bacterial growth | Coxiella burnetii | 3 | organism-based format | Scientific Literature | ||
18. | ALA5252145 | T | Cytotoxicity against human HepG2 cells | Homo sapiens | 3 | cell-based format | Scientific Literature |